Two Sigma Advisers’s Karyopharm Therapeutics KPTI Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-5,107
| Closed | -$51.8K | – | 2489 |
|
2024
Q4 | $51.8K | Buy |
5,107
+3,027
| +146% | +$30.7K | ﹤0.01% | 2279 |
|
2024
Q3 | $25.9K | Buy |
+2,080
| New | +$25.9K | ﹤0.01% | 2244 |
|
2024
Q1 | – | Sell |
-4,213
| Closed | -$54.7K | – | 2553 |
|
2023
Q4 | $54.7K | Buy |
4,213
+1,866
| +80% | +$24.2K | ﹤0.01% | 2394 |
|
2023
Q3 | $47.2K | Sell |
2,347
-15,000
| -86% | -$301K | ﹤0.01% | 2280 |
|
2023
Q2 | $466K | Sell |
17,347
-9,420
| -35% | -$253K | ﹤0.01% | 1833 |
|
2023
Q1 | $1.56M | Sell |
26,767
-20,113
| -43% | -$1.17M | ﹤0.01% | 1402 |
|
2022
Q4 | $2.39M | Sell |
46,880
-8,540
| -15% | -$436K | 0.01% | 1138 |
|
2022
Q3 | $4.54M | Sell |
55,420
-10,313
| -16% | -$845K | 0.01% | 778 |
|
2022
Q2 | $4.45M | Buy |
65,733
+14,046
| +27% | +$950K | 0.01% | 827 |
|
2022
Q1 | $5.71M | Buy |
51,687
+23,180
| +81% | +$2.56M | 0.02% | 749 |
|
2021
Q4 | $2.75M | Sell |
28,507
-43,626
| -60% | -$4.21M | 0.01% | 1036 |
|
2021
Q3 | $6.3M | Buy |
72,133
+6,640
| +10% | +$580K | 0.02% | 688 |
|
2021
Q2 | $10.1M | Buy |
65,493
+4,813
| +8% | +$745K | 0.03% | 558 |
|
2021
Q1 | $9.58M | Buy |
60,680
+26,887
| +80% | +$4.24M | 0.03% | 589 |
|
2020
Q4 | $7.85M | Sell |
33,793
-45,267
| -57% | -$10.5M | 0.02% | 653 |
|
2020
Q3 | $17.3M | Buy |
79,060
+18,827
| +31% | +$4.12M | 0.05% | 358 |
|
2020
Q2 | $17.1M | Buy |
60,233
+11,426
| +23% | +$3.25M | 0.05% | 369 |
|
2020
Q1 | $14.1M | Buy |
48,807
+13,860
| +40% | +$3.99M | 0.05% | 375 |
|
2019
Q4 | $10M | Buy |
34,947
+21,380
| +158% | +$6.15M | 0.02% | 599 |
|
2019
Q3 | $1.96M | Sell |
13,567
-6,186
| -31% | -$893K | ﹤0.01% | 1121 |
|
2019
Q2 | $1.78M | Sell |
19,753
-4,954
| -20% | -$445K | ﹤0.01% | 1262 |
|
2019
Q1 | $2.16M | Buy |
24,707
+9,140
| +59% | +$801K | 0.01% | 1186 |
|
2018
Q4 | $2.19M | Sell |
15,567
-326
| -2% | -$45.8K | 0.01% | 1137 |
|
2018
Q3 | $4.06M | Buy |
15,893
+5,460
| +52% | +$1.39M | 0.01% | 908 |
|
2018
Q2 | $2.66M | Buy |
+10,433
| New | +$2.66M | 0.01% | 1169 |
|